Safety of concurrent initiation of antidepressants and ADHD medications in adults with depression and ADHD

Adults with attention-deficit/hyperactivity disorder (ADHD) and comorbid depression often require combined treatment with antidepressants and ADHD medications, yet population-based safety data are limited. This nationwide cohort study used the South Korea Health Insurance Review and Assessment Service database (2013–2022). Adults aged 18 years or older with ADHD and depressive disorder who initiated antidepressants were included. Antidepressant initiation alone was compared with same-day initiation of an antidepressant and an ADHD medication (methylphenidate, atomoxetine, and/or clonidine). Propensity score matching (1:1) was applied. Neuropsychiatric outcomes included suicidal events, mania, anxiety disorder, sleep disorder, and tic disorder; secondary outcomes included hypertension. Hazard ratios (HRs) and 95% CIs were estimated using Cox models. The reference matched cohort comprised 8,592 pairs; outcome-specific cohorts were matched separately. Compared with antidepressant monotherapy, combination therapy was associated with higher risks of tic disorder (HR, 1.75; 95% CI, 1.31–2.35) and hypertension (HR, 1.80; 95% CI, 1.24–2.69). In subgroup analyses (1,213 reference matched pairs), methylphenidate-based combinations were associated with higher risks of headache and sleep disorder, although the sleep-disorder confidence interval only narrowly excluded 1. Tic disorder did not differ significantly. No significant differences were observed for mania or anxiety disorder. Suicidal events were too sparse for reliable inference. In this nationwide cohort study, same-day initiation of antidepressants and ADHD medications in adults showed no statistically significant differences for most major neuropsychiatric outcomes but was associated with higher risks of hypertension and tic disorder. These findings support monitoring after treatment initiation; sparse events and short follow-up limit drug-specific and longer-term safety conclusions.

Authors

Institutions

Publication Details

Journal
BMC Psychiatry
Published
2026-11-19
DOI
https://doi.org/10.1186/s12888-026-08898-x
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Safety of concurrent initiation of antidepressants and ADHD medications in adults with depression and ADHD

Nayeong Kong, 신윤미, Dong Yun Lee, Jaehyeong Cho et al.
BMC Psychiatry
Attention Deficit Hyperactivity Disorder
article

Safety of concurrent initiation of antidepressants and ADHD medications in adults with depression and ADHD

Nayeong Kong, 신윤미, Dong Yun Lee, Jaehyeong Cho, Hojun Lee
article en

Abstract

Adults with attention-deficit/hyperactivity disorder (ADHD) and comorbid depression often require combined treatment with antidepressants and ADHD medications, yet population-based safety data are limited. This nationwide cohort study used the South Korea Health Insurance Review and Assessment Service database (2013–2022). Adults aged 18 years or older with ADHD and depressive disorder who initiated antidepressants were included. Antidepressant initiation alone was compared with same-day initiation of an antidepressant and an ADHD medication (methylphenidate, atomoxetine, and/or clonidine). Propensity score matching (1:1) was applied. Neuropsychiatric outcomes included suicidal events, mania, anxiety disorder, sleep disorder, and tic disorder; secondary outcomes included hypertension. Hazard ratios (HRs) and 95% CIs were estimated using Cox models. The reference matched cohort comprised 8,592 pairs; outcome-specific cohorts were matched separately. Compared with antidepressant monotherapy, combination therapy was associated with higher risks of tic disorder (HR, 1.75; 95% CI, 1.31–2.35) and hypertension (HR, 1.80; 95% CI, 1.24–2.69). In subgroup analyses (1,213 reference matched pairs), methylphenidate-based combinations were associated with higher risks of headache and sleep disorder, although the sleep-disorder confidence interval only narrowly excluded 1. Tic disorder did not differ significantly. No significant differences were observed for mania or anxiety disorder. Suicidal events were too sparse for reliable inference. In this nationwide cohort study, same-day initiation of antidepressants and ADHD medications in adults showed no statistically significant differences for most major neuropsychiatric outcomes but was associated with higher risks of hypertension and tic disorder. These findings support monitoring after treatment initiation; sparse events and short follow-up limit drug-specific and longer-term safety conclusions.

BMC Psychiatry
Keimyung University Dongsan Medical Center (KR), Keimyung University Dongsan Hospital (KR), Keimyung University (KR), Ajou University (KR)
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon